FIG. 1 is a perspective view of a first embodiment of the container, showing the new design;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a side view thereof;
FIG. 5 is a top view thereof;
FIG. 6 is a bottom view thereof;
FIG. 7 is a perspective view of a plurality of the containers of FIG. 1 arranged in a package according to a second embodiment of the present invention.
FIG. 8 is a front view thereof;
FIG. 9 is a rear view thereof;
FIG. 10 is a side view thereof;
FIG. 11 is a top view thereof; and,
FIG. 12 is a bottom view thereof.
The broken line showing on the container in FIGS. 1-12 is included for the purpose of illustrating environment and forms no part of the claimed design.
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 03 2012 | CEHAJIC, NERMIN | Nephron Pharmaceuticals Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 028193 | /0359 |
pdf |
May 11 2012 | | Nephron Pharmaceuticals Corporation | (assignment on the face of the patent) | | / |
Aug 07 2014 | Nephron Pharmaceuticals Corporation | LBC CREDIT PARTNERS III, L P , AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036904 | /0060 |
pdf |
Aug 11 2017 | LBC CREDIT PARTNERS III, L P | Nephron Pharmaceuticals Corporation | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 043309 | /0239 |
pdf |
Aug 11 2017 | Nephron Pharmaceuticals Corporation | PNC Bank, National Association | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 043309 | /0435 |
pdf |
Aug 14 2018 | Nephron Pharmaceuticals Corporation | PNC Bank, National Association | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 046802 | /0966 |
pdf |
Sep 11 2023 | Nephron Pharmaceuticals Corporation | PNC Bank, National Association | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 064861 | /0641 |
pdf |
Dec 30 2024 | NEPRON PHARMACEUTICALS, LLC, F K A NEPHRON PHARMACEUTICALS CORPORATION | WHITEHAWK CAPITAL PARTNERS, LP | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 070037 | /0531 |
pdf |
Dec 30 2024 | PNC Bank, National Association | Nephron Pharmaceuticals Corporation | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 070037 | /0162 |
pdf |